SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bruner, L H
Right arrow Articles by Curren, R D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruner, L H
Right arrow Articles by Curren, R D
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

An investigation of new toxicity test method performance in validation studies: 3. sensitivity and specificity are not independent of prevalence or distribution of toxicity

L H Bruner

Gillette Environment, Health & Safety, Needham, Massachusetts, USA; leon_bruner{at}gillette.com

G J Carr

The Procter & Gamble Company, Miami Valley Laboratories, Cincinnati, Ohio, USA

J W Harbell

R D Curren

Institute for In Vitro Sciences, Gaithersburg, Maryland, USA

Often, the only measures of toxicity test performance provided in validation studies are the contingent probability statistics (CPS) sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Sensitivity and specificity are generally used in preference to NPV and PPV since NPV and PPV are assumed to vary with changes in prevalence while sensitivity and specificity are assumed to be independent of changes in prevalence. The purpose of the studies reported here was to test whether or not sensitivity and specificity are actually independent of changes in prevalence. Results derived from these studies indicate that sensitivity and specificity vary significantly depending on the prevalence of toxic substances in the set of chemicals being tested. This means sensitivity and specificity should not always be considered constant indicators of toxicity test performance.

Key Words: correlation • negative predictive value • positive predictive value • prediction interval • prevalence • sensitivity • specificity • toxicity test performance measurement • toxicity test validation • validation

Human & Experimental Toxicology, Vol. 21, No. 6, 325-334 (2002)
DOI: 10.1191/0960327102ht254oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
S. Hoffmann and T. Hartung
Diagnosis: Toxic! - Trying to Apply Approaches of Clinical Diagnostics and Prevalence in Toxicology Considerations
Toxicol. Sci., May 1, 2005; 85(1): 422 - 428.
[Abstract] [Full Text] [PDF]



Advertisement